We Bring Innovation to Life

Supporting high volume drug delivery

Bring your innovation to life with Molly® 2.25, a high-volume variation of SHL’s classic Molly® auto injector, designed with improved features for enhanced production and usability

Meet us at the PDA Japan Pre-filled Syringe Seminar

May 21-22, 2019 | Tokyo, Japan | Stand 11

Molly® 2.25

Molly® is an incredibly intuitive and easy-to-use auto injector built with a preconfigured technology developed to minimize customer investments and speed up development timelines.

Bigger Volume

Close

Built for higher volume injections, Molly® 2.25 supports the trends for injection volumes in the 1-2.25mL range. This allows new drugs to be delivered in auto injectors and launched products to be dosed less frequently.

Better Grip

Close

Deepened ridges on Molly®’s cap enhances grip. Its flare-shaped top facilitates cap removal, and its rectangular contour prevents unwanted rolling to ance the device’s safety.

Easier Handling

Close

As a preconfigured offering, Molly® 2.25 is designed to be easily understood and accepted by a variety of patient groups. Having inherited the classic Molly®’s 2-step process, Molly® 2.25 is as compact, intuitive and easy to use.

Faster Timelines

Close

SHL’s final assembly, labeling and packaging services were established to create added value for our partners following the successful design and development of their device, resulting in a fully integrated service from device design to commercialization.

Preconfigured Technology

Close

A high-volume variation of SHL's classic Molly® auto injector, Molly® 2.25 is a preconfigured device that can also support various levels of customization to meet client specifications. 

Preconfigured Technology

A high-volume variation of SHL's classic Molly® auto injector, Molly® 2.25 is a preconfigured device that can also

support various levels of customization

to meet client specifications. 

Easier Handling

As a preconfigured offering, Molly® 2.25 is designed to be easily understood and accepted by a variety of patient groups. Having inherited the classic Molly®’s 2-step process, Molly® 2.25 is as compact, intuitive and easy to use.

Better Grip

Deepened ridges on Molly®’s cap enhances grip. Its flare-shaped top facilitates cap removal, and its rectangular contour prevents unwanted rolling to enhance the device’s safety.

Bigger Volume

Built for higher volume injections, Molly® 2.25 supports the trends for injection volumes in the 1-2.25mL range. This allows new drugs to be delivered in auto injectors and launched products to be dosed less frequently.

Faster Timelines

SHL’s final assembly, labeling and packaging services were established to create added value for our partners following the successful design and development of their device, resulting in a fully integrated service from device design to commercialization.

Go to article: Home | Where is my mind?Go to article: In this issueGo to article: Scandinavian Health Company InsightGo to article: Scandinavian HealthGo to article: ContentsGo to article: NSFGo to article: NewsGo to article: Daiichi JitsugyoGo to article: The pharma industry briefingGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Thumbs up for esketamine sheds light on potential for ketamineGo to article: Phoenix group Company InsightGo to article: Phoenix group Go to article: Charting the life and times of the EMA as it leaves LondonGo to article: Swiss WorldCargoGo to article: Capsugel Company InsightGo to article: CapsugelGo to article: Medical cannabis in the UK: how has the roll out gone so far? Go to article: EmboCapsGo to article: Barc Lab Go to article: Drug development: the researchers driving an open-science approachGo to article: Freudenberg MedicalGo to article: AlbypharmaGo to article: The drugs fighting memory lossGo to article: Senn ChemicalsGo to article: Pharma HempGo to article: RUNLABS: empowering life science through flexible working environmentsGo to article: Spirax SarcoGo to article: Spirax Sarco Company InsightGo to article: EventsGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: B&W TekGo to article: Next issueGo to article: PfanstiehlGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Hapa Company InsightGo to article: Contract Pharmaceuticals Limited Canada